©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: FDA
New Vapor Cartridge Technology
STILLWATER, Minn. -- According to Timothy L. McCullough inventor and owner of Vapor Cartridge Technology LLC. "Vapor Cartridge Technologywas designed to revive the legal...
U.S. Health Officials Recommend Schedule III for Cannabis
WASHINGTON – The U.S. Department of Health and Human Services (HHS) has recommended reclassifying cannabis from Schedule I to a less restrictive Schedule III...
Brazilian Entrepreneur Bringing Revolutionary Hemp Products to U.S. Marketplace
BOCA RATON, Fla. --
Entourage Labs is thrilled to announce its impending debut into the U.S. marketplace, introducing a range of groundbreaking hemp-based products. Founded...
LightLab 3 Cannabis Analyzer Chosen by FDA to Enhance Consumer Safety and Regulation in...
NEW LONDON, N.H. --
Orange Photonics, a pioneer in revolutionizing HPLC technology, is proud to announce that the US Food and Drug Administration (FDA) has...
What the 2023 Farm Bill Could Mean for CBD and Other Cannabinoids
The 2018 Farm Bill revolutionized the hemp landscape, jump-starting an industry currently valued at more than $4 billion and expected to reach $16 billion...
Feds Signal Delta-8 Edibles Crackdown in New Warnings
SILVER SPRING, Md. – The federal government is cracking down on delta-8 edibles that resemble popular snack foods, according to letters two agencies sent...
Will Psychedelics Succeed Where Cannabis Has Struggled?
Plant-based medicines and therapeutics finally are gaining significant traction with the medical establishment. After decades of closed-mindedness, it’s about time.
However, the bright spotlight on...
Zelira secures US$8.6 million cornerstone funding for FDA clinical trials for HOPE-1(R) Cannabinoid Medicine...
Zelira Therapeutics Ltd (ASX:ZLD, OTCQB:ZLDAF), a global leader in the development and commercialization of clinically validated cannabinoid-based medicines, is delighted to announce that it...
National Cannabis Industry Association Responds to FDA Statement on Cannabidiol (CBD) Regulation
Washington, DC – The Food and Drug Administration announced that it has concluded that regulations governing food and supplements would not be appropriate for...
FDA Issues Guidance for Clinical Research & Product Development
SILVER SPRING, M.D. – The Federal Drug Administration's (FDA) Center for Drug Evaluation and Research issued its final nonbinding recommendations for clinical cannabis research...